{"id":617180,"title":"Clinical Trial Application - Amendments (CTA-As) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-03","captureTimestamp":"2026-03-03T04:35:21.662000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/application-amendments.html","snippet":"Clinical Trial Application - Amendments (CTA-As) CTA-A s are applications in which a sponsor proposes information to support changes to a previously authorized application [ C.05.008 ]. Where a sponsor wishes to make changes to a CTA under review, the sponsor should withdraw the…","rawSnapshotUrl":"/api/snapshots/raw/617180","browseUrl":"https://replay.healtharchive.ca/job-6/20260303043521/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/application-amendments.html#ha_snapshot=617180","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}